Company intelligence / Profile preview

Oakwood Laboratories

Oakwood Village, Ohio, United Statesoakwoodlabs.com ↗

Ownership: Private
Employees: ~85
Development stage: Other

Overview

Oakwood Laboratories has developed multiple sustained-release injectable formulations using its Chroniject™ technology. The most advanced programs have reached Phase III global clinical trials. The company currently manufactures five commercial products for clients and partners.

Therapeutic areas: PsychiatryRheumatologyOphthalmologyEndocrinologyDermatologyOtherOncologyNeurology
Modalities: Small moleculePeptidesProteinsPolymer-drug conjugate therapy (via microsphere technology)Hormone
Industry: Biotech

Partnerships

Strategic global partnerships for polymer/raw material supply; partners with small and large pharmaceutical companies globally for development/manufacturing services. Specific partner names are not disclosed publicly.

Beyond the preview

Go deeper on Oakwood Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oakwood Laboratories.